Endoscopic Ultrasound Shear Wave Elastography Study (NCT06592820)
Endoscopic Ultrasound With Shear Wave Elastography for the Assessment of Liver Disease
🩺 Plain-English Summary (8th-Grade Level)
This study shall be a prospective, multicenter, single arm, consecutive, interventional study conducted in a post-market setting using commercially available devices. Consecutive, eligible patients with clinical suspicion of MASLD or MASH reporting for an endoscopic ultrasound and liver biopsy for evaluation of fibrosis will be enrolled. EUS Shear Wave Elastography and Attenuation Imaging technologies will be compared to liver biopsy and FibroScan results and other non-invasive fibrosis screening modalities . The data collected during this study will be evaluated in accordance with the procedures set forth in the protocol. The main question\[s\] it aims to answer are: * Establish optimal cutoffs for EUS-SWE in reference to liver biopsies staging system for liver fibrosis * Evaluate the diagnostic performance of EUS-SWE compared to FibroScan (VCTE) and to other non-invasive fibrosis screening modalities (screening scores). Participants will undergo: * Endoscopic Ultrasound with Shear Wave Elastography (SWE) and Attenuation Imaging (ATI) * Liver biopsy * FibroScan
Who can join: Review the eligibility criteria below.
Location: Brigham and Women's Hospital — Boston, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Brigham and Women's Hospital — Boston, Massachusetts
- Geisinger Medical Center — Danville, Pennsylvania
📞 Contact the Study Coordinator
Phone: (408) 941-3623
Email: octavia.plingu@olympus.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in MASLD
- Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis — Birmingham, Alabama
- Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease — Detroit, Michigan
- Accurate Point of Care Liver Disease Diagnostics (Phase 2) — La Jolla, California
- Quantitative Ultrasound to Assess Steatotic Liver Disease in Children — La Jolla, California
- A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease — Nashville, Tennessee
Explore by condition: All MASLD clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.